These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 24563441)
1. Prognostic and predictive significance of plasma hepatocyte growth factor and carcinoembryonic antigen in non-small lung cancer after surgery. Fang MY; Wang SY; Zheng YB; Gong LY; Bao WL; Gu DL; Mao WM Eur Rev Med Pharmacol Sci; 2014; 18(3):398-403. PubMed ID: 24563441 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117 [TBL] [Abstract][Full Text] [Related]
3. Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer. Gupta A; Karakiewicz PI; Roehrborn CG; Lotan Y; Zlotta AR; Shariat SF Clin Cancer Res; 2008 Nov; 14(22):7385-90. PubMed ID: 19010854 [TBL] [Abstract][Full Text] [Related]
4. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer. Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963 [TBL] [Abstract][Full Text] [Related]
5. Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status. Kato T; Ishikawa K; Aragaki M; Sato M; Okamoto K; Ishibashi T; Oba K; Kaji M J Surg Oncol; 2013 May; 107(6):619-24. PubMed ID: 23192365 [TBL] [Abstract][Full Text] [Related]
6. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer. Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687 [TBL] [Abstract][Full Text] [Related]
7. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308 [TBL] [Abstract][Full Text] [Related]
9. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis. Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage? Kawachi R; Nakazato Y; Takei H; Koshi-ishi Y; Goya T Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):199-202. PubMed ID: 19457896 [TBL] [Abstract][Full Text] [Related]
11. Significance of the serum carcinoembryonic antigen level during the follow-up of patients with completely resected non-small-cell lung cancer. Ozeki N; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ito S; Sakao Y; Mitsudomi T; Hirakawa A; Yokoi K Eur J Cardiothorac Surg; 2014 Apr; 45(4):687-92. PubMed ID: 23979987 [TBL] [Abstract][Full Text] [Related]
12. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084 [TBL] [Abstract][Full Text] [Related]
13. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis. Matsuguma H; Nakahara R; Igarashi S; Ishikawa Y; Suzuki H; Miyazawa N; Honjo S; Yokoi K J Thorac Cardiovasc Surg; 2008 Jan; 135(1):44-9. PubMed ID: 18179917 [TBL] [Abstract][Full Text] [Related]
14. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660 [TBL] [Abstract][Full Text] [Related]
15. Serum carcinoembryonic antigen level in pN1 non-small cell lung cancer patients. Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T Anticancer Res; 2005; 25(5):3601-5. PubMed ID: 16101187 [TBL] [Abstract][Full Text] [Related]
16. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer]. Zhang ZF; Ma JQ; Sun N; Zhang L Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):817-9. PubMed ID: 15363304 [TBL] [Abstract][Full Text] [Related]
17. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected. Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187 [TBL] [Abstract][Full Text] [Related]
18. Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer. Han JY; Kim JY; Lee SH; Yoo NJ; Choi BG Lung Cancer; 2011 Nov; 74(2):293-9. PubMed ID: 21440951 [TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen as prognostic factor for metastatic non-small cell lung cancer by percutaneous cryosurgery. Li H; Tang K; Niu L; Liang Y; Li J; Chen J; Xu K Cancer Biomark; 2013; 13(5):337-43. PubMed ID: 24440973 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]